TY  - GEN
AU  - Micallef,Ivana N M
AU  - Kahl,Brad S
AU  - Maurer,Matthew J
AU  - Dogan,Ahmet
AU  - Ansell,Stephen M
AU  - Colgan,Joseph P
AU  - Geyer,Susan
AU  - Inwards,David J
AU  - White,William L
AU  - Habermann,Thomas M
TI  - A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma
SN  - 0008-543X
PY  - 2007///0212
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Doxorubicin
KW  - Female
KW  - Humans
KW  - Lymphoma, B-Cell
KW  - drug therapy
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - Male
KW  - Middle Aged
KW  - Pilot Projects
KW  - Prednisone
KW  - Rituximab
KW  - Treatment Outcome
KW  - Vincristine
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/cncr.22342
ER  -